Clinical Trial Update: A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent [Phase 3]

View source ↗

Summary

This document announces a Phase 3 clinical trial evaluating Centhaquine as a resuscitative agent for hypovolemic shock; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypovolemic Shock

Drugs mentioned

• Centhaquine (Centhaquine)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Hypovolemic Shock | Phase 3 | Status: NOT_YET_RECRUITING